Eicosanoids and lipocortin-1 in BAL fluid in asthma: Effects of smoking and inhaled glucocorticoids

Journal of Applied Physiology

Volumn 81, Issue 2, 1996, Pages 548-555

  Van Hal, Peter T W ^b   Overbeek, Shelley E ^b   Hoogsteden, Henk C ^b   Zijlstra, Freek J ^b   Murphy, Kevin ^b   Oosterhoff, Ytske ^b   Postma, Dirkje S ^b   Guz, Abraham ^b   Smith, Susan F ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NONE

Author keywords

beclomethasone; bronchial hyperresponsiveness; bronchoalveolar lavage; prostaglandin D2

Indexed keywords

GLUCOCORTICOID; ICOSANOID; LIPOCORTIN 1; PROSTAGLANDIN D2;

ADULT; ARTICLE; ASTHMA; BINDING SITE; BRONCHUS HYPERREACTIVITY; CIGARETTE SMOKING; CLINICAL ARTICLE; FEMALE; HUMAN; ICOSANOID METABOLISM; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG LAVAGE; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0029769298     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.81.2.548     Document Type: Article

References (33)

1. Ambrose, M. P., C.-L. C. Bahns, and G.. Hunninghake. Lipocortin 1 production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 6: 17-21, 1992.
2. Ambrose, M. P., and G. W. Hunninghake. Corticosteroids increase lipocortin I in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 3: 349-353, 1990.
3. Ambrose, M. P., and G. W. Hunninghake. Corticosteroids increase lipocortin I in BAL fluid from normal individuals and patients with lung disease. J. Appl. Physiol. 68: 1668-1671, 1990.
4. Barnes, P. J., and I. Adcock. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14: 436-441, 1993.
5. Barnes, P. J., K. F. Chung, and C. P. Page. Inflammatory mediators. In: Handbook of Experimental Pharmacology. Pharmacology of Asthma, edited by C. P. Page and P. J. Barnes. Berlin: Springer-Verlag, 1991, vol. 98, p. 53-106.
6. Brand, P. L. P., H. A. M. Kerstjens, D. S. Postma, P. J. Sterk, P. H. Quanjer, H. J. Sluiter, J. H. Dijkman, C. L. A. Van Herwaarden, C. Hilvering, H. M. Jansen, G. H. Koëter, J. Kreukniet, and the Dutch Chronic Non-specific Lung Disease Study Group. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Eur. Respir. J. 5: 21-31, 1992
7. Browning, J. L., M. P. Ward, B. P. Wallner, and R. B. Pepinsky. Studies on the structural properties of lipocortin and the regulation of its synthesis by steroids. In: Cytokines and Lipocortins in Inflammation and Differentiation, edited by M. Melli and L. Parente. New York: Wiley-Liss, 1990, p. 27-45.
8. Cirino, G., R. J. Flower, J. L. Browning, L. K. Sinclair, and R. B. Pepinsky. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature Lond. 328: 270-272, 1987.
9. Croxtall, J. D., Q. Choudhury, H. Tokumoto, and R. J. Flower. Lipocortin-1 and the control of arachidonic acid release in cell signalling. Biochem. Pharmacol. 50: 465-474, 1995.
10. De Caterina R., R. Sicari, D. Giannessi, P. L. Paggiaro, P. Paoletti, G. Lazzerini, W. Bernini, E. Solito, and L. Parente. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J. Appl. Physiol. 75: 2368-2375, 1993.
11. Flower, R. J., and N. J. Rothwell. Lipocortin 1: cellular mechanisms and clinical relevance. Trends Pharmacol. Sci. 15: 71-76, 1994.
12. Goulding, N. J., P. Luying, and P. M. Guyre. Characteristics of lipocortin 1 binding to the surface of human peripheral blood leukocytes. Biochem. Soc. Trans. 18: 1237-1238, 1990.
13. Jacquot, J., F. Dupuir, H. Elbtaourri, J. Hinnrasky, F. Antonicelli, B. Haye, and E. Puchelle. Production of lipocortin-like proteins by cultured human tracheal submucosal gland cells. FEBS Lett. 274: 131-135, 1990.
14. Juniper, E. F., P. A. Kline, M. A. Vanzieleghem, E. H. Ramsdale, P. M. O'Byrne, and F. E. Hargreave. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am. Rev. Respir. Dis. 142: 832-836, 1990.
15. Kerstjens, H. A. M., P. L. P. Brand, M. D. Hughes, N. J. Robinson, D. S. Postma, H. J. Sluiter, E. R. Bleecker, P. N. R. Dekhuijzen, P. M. De Jong, H. J. J. Mengelers, S. E. Overbeek, D. F. M. E. Schoonbrood, and the Dutch Chronic Non-specific Lung Disease Study Group. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N. Engl. J. Med. 327: 1413-1419, 1992.
16. Leff, A. R., K. J. Hamann, and C. D. Wegner. Inflammation and cell-cell interactions in airway hyperresponsiveness. Am. J. Physiol. 260 (Lung Cell. Mol. Physiol. 4): L189-L206, 1990.
17. Lowry, O. H., J. J. Roseborough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
18. Oosterhoff, Y., H. F. Kauffman, B. Rutgers, F. J. Zijlstra, G. H. Koëter, and D. S. Postma. Inflammatory cell number and mediators in bronchoalveolar lavage fluid and peripheral blood in subjects with asthma with increased nocturnal airways narrowing. J. Allergy Clin. Immunol. 96: 219-229, 1995.
19. Peers, S. H., F. Smillie, A. J. Elderfield, and R. J. Flower. Glucocorticoid and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leukocytes in vivo. Br. J. Pharmacol. 108: 66-72, 1993.
20. Perretti, M., and R. J. Flower. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J. Immunol. 150: 992-999, 1993.
21. Relton, J. K., P. J. L. M. Strijbos, C. T. O'Shaughnessy, F. Carey, R. A. Forder, F. J. H. Tilders, and N. J. Rothwell. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J. Exp. Med. 174: 305-310, 1991.
22. Robinson, D. S., S. Ying, A. M. Bentley, Q. Meng, J. North, S. R. Durham, A. B. Kay, and Q. Hamid. Relationship among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92: 397-403, 1993.
23. Smith, S. F., N. J. Goulding, J. L. Godolphin, T. D. Tetley, C. M. Roberts, A. Guz, and R. J. Flower. An assay for the assessment of lipocortin 1 levels in human lung lavage fluid. J. Immunol. Methods 131: 119-125, 1990.
24. Smith, S. F., N. J. Goulding, T. D. Tetley, J. L. Godolphin, A. Guz, and R. J. Flower. A possible anti-inflammatory mechanism for glucocorticoids in the human lung (Abstract). Clin. Sci. Lond. 77, Suppl. 21:20P, 1989.
25. Smith, S. F., A. Guz, N. T. Cooke, G. H. Burton, and T. D. Tetley. Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers. Clin. Sci. Lond. 69: 17-27, 1985.
26. Smith, S. F., A. Guz, H. C. Hoogsteden, and P. T. W. van Hal. Extracellular lipocortin 1 (Lc1) levels in bronchoalveolar lavage fluid (BALF) from smokers (Sm) and non-smokers (NSm) (Abstract). Am. Rev. Respir. Dis. 145: A381, 1992.
27. Smith, S. F., A. Guz, A. J. Winning, N. T. Cooke, G. H. Burton, and T. D. Tetley. Comparison of human lung surface protein profiles from the central and peripheral airways sampled using two regional lavage techniques. Eur. Respir. J. 1: 792-800, 1988.
28. Smith, S. F., T. D. Tetley, A. K. Datta, T. Smith, A. Guz, and R. J. Flower. Lipocortin-1 distribution in bronchoalveolar lavage from healthy human lung: effect of prednisolone. J. Appl. Physiol. 79: 121-128, 1995.
29. Smith, T., S. F. Smith, R. J. Flower, and J. C. Buckingham. Endotoxin and the expression of lipocortins in central and peripheral tissues of the rat (Abstract). Br. J. Pharmacol. 104: 218P, 1991.
30. Sparrow, D., G. T. O'Connor, B. Rosner, D. Demolles, and S. T. Weiss. A longitudinal study of plasma cortisol concentrations in pulmonary function decline in man. Am. Rev. Respir. Dis. 147: 1345-1348, 1993.
31. Task Group Appointed by the American Thoracic Society Scientific Assembly on Clinical Problems. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136: 225-244, 1987.
32. Van Hal, P. T. W., S. E. Overbeek, H. C. Hoogsteden, F. J. Zijlstra, T. D. Tetley, K. Murphy, Y. Oosterhof, D. S. Postma, and S. F. Smith. Lipocortin 1 in lung lavage from allergic asthmatics (Abstract). Inflammation Res. 44, Suppl. 3: S291, 1995.
33. Vishwanath, B. S., F. J. Frey, M. Bradbury, M. F. Dallman, and B. M. Frey. Adrenalectomy decreases lipocortin-I messenger ribonucleic acid and tissue protein content in rats. Endocrinology 130: 585-591, 1992.